Minna Tanner

Department of Oncology, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, P.O. Box 100, FI-33014, Tampere, Finland.

View Article and Find Full Text PDF

July 2019

Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.

Authors:

Leena Tiainen Mari Hämäläinen Tiina Luukkaala Minna Tanner Outi Lahdenperä Pia Vihinen Arja Jukkola Peeter Karihtala Eeva Moilanen Pirkko-Liisa Kellokumpu-Lehtinen

Clin Breast Cancer 2019 08 4;19(4):e522-e533. Epub 2019 Apr 4.

Department of Oncology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Department of Oncology, Tampere University Hospital, Tampere, Finland.

View Article and Find Full Text PDF

August 2019

Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.

Authors:

Satu Luhtala Synnöve Staff Anne Kallioniemi Minna Tanner Jorma Isola

BMC Cancer 2018 Oct 26;18(1):1045. Epub 2018 Oct 26.

BioMediTech Institute and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Arvo Ylpön katu 34, 33520, Tampere, Finland.

View Article and Find Full Text PDF

October 2018

Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial.

JAMA Oncol 2018 09;4(9):1199-1206

Uppsala University Hospital, Uppsala, Sweden.

View Article and Find Full Text PDF

September 2018

Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.

Authors:

Heikki Joensuu Pirkko-Liisa Kellokumpu-Lehtinen Riikka Huovinen Arja Jukkola-Vuorinen Minna Tanner Riitta Kokko Johan Ahlgren Päivi Auvinen Outi Lahdenperä Sanna Kosonen Kenneth Villman Paul Nyandoto Greger Nilsson Paula Poikonen-Saksela Vesa Kataja Jouni Junnila Petri Bono Henrik Lindman

JAMA Oncol 2017 Jun;3(6):793-800

Uppsala University Hospital, Uppsala, Sweden.

View Article and Find Full Text PDF

June 2017

Bevacizumab Combined with Docetaxel or Paclitaxel as First-line Treatment of HER2-negative Metastatic Breast Cancer.

Authors:

Leena Tiainen Minna Tanner Outi Lahdenperä Pia Vihinen Arja Jukkola Peeter Karihtala Niina Paunu Teppo Huttunen Pirkko-Liisa Kellokumpu-Lehtinen

Anticancer Res 2016 12;36(12):6431-6438

Department of Oncology, School of Medicine, University of Tampere, Tampere, Finland.

View Article and Find Full Text PDF

December 2016

Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity Cohort.

Authors:

Renée T Fortner Helena Schock Rudolf Kaaks Matti Lehtinen Eero Pukkala Hans-Åke Lakso Minna Tanner Raija Kallio Heikki Joensuu Jaana Korpela Adetunji T Toriola Göran Hallmans Kjell Grankvist Anne Zeleniuch-Jacquotte Paolo Toniolo Eva Lundin Heljä-Marja Surcel

Cancer Res 2017 01 26;77(1):134-141. Epub 2016 Oct 26.

Department of Health Protection, National Institute for Health and Welfare, Oulu, Finland.

View Article and Find Full Text PDF

January 2017

Comparison of Antibodies for Immunohistochemistry-based Detection of HER3 in Breast Cancer.

Authors:

Satu Luhtala Synnöve Staff Mark Barok Minna Tanner Jorma Isola

Appl Immunohistochem Mol Morphol 2018 Mar;26(3):212-219

BioMediTech, University of Tampere, Tampere.

View Article and Find Full Text PDF

March 2018

Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.

Authors:

Satu Luhtala Synnöve Staff Minna Tanner Jorma Isola

Tumour Biol 2016 Jul 26;37(7):9813-23. Epub 2016 Jan 26.

Laboratory of Cancer Biology, BioMediTech, University of Tampere, FI-33014, Tampere, Finland.

View Article and Find Full Text PDF

July 2016

Does patient education work in breast cancer? Final results from the global CARIATIDE study.

Authors:

Christos Markopoulos Patrick Neven Minna Tanner Michael Marty Rolf Kreienberg Louise Atkins Ann Franquet Michael Gnant Silvia Neciosup Petra Tesarova Sandro Barni Veronique Deschamp

Future Oncol 2015 ;11(2):205-17

Breast Unit, Athens University Medical School, Athens, Greece.

View Article and Find Full Text PDF

September 2015

Early pregnancy sex steroids and maternal breast cancer: a nested case-control study.

Authors:

Renée T Fortner Helena Schock Rudolf Kaaks Matti Lehtinen Eero Pukkala Hans-Åke Lakso Minna Tanner Raija Kallio Heikki Joensuu Kjell Grankvist Anne Zeleniuch-Jacquotte Paolo Toniolo Eva Lundin Helja-Marja Surcel

Cancer Res 2014 Dec 3;74(23):6958-67. Epub 2014 Oct 3.

Unit of Sexual and Reproductive Health, National Institute for Health and Welfare, Oulu, Finland.

View Article and Find Full Text PDF

December 2014

The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (CARIATIDE) study.

Authors:

Patrick Neven Christos Markopoulos Minna Tanner Michel Marty Rolf Kreienberg Louise Atkins Ann Franquet Michael Gnant Silvia Neciosup Petra Tesarova Sandro Barni Veronique Deschamp

Breast 2014 Aug 24;23(4):393-9. Epub 2014 Mar 24.

AstraZeneca, Brussels, Belgium.

View Article and Find Full Text PDF

August 2014

Bi-weekly paclitaxel and capecitabine as a second- or third-line treatment for advanced breast cancer: a pilot study.

Authors:

Pirkko-Liiisa Kellokumpu-Lehtinen Tuija Tuunanen Anna-Liisa Kautio Ilari Lehtinen Minna Tanner

Anticancer Res 2013 Nov;33(11):4941-5

Ph.D. Professor of Radiotherapy and Oncology, Tampere University, School of Medicine, Tampere University Hospital, B.O.X. 607, FIN 33101 Tampere, Finland.

View Article and Find Full Text PDF

November 2013